Scholarly Index
François‐Clément Bidard
Inserm; 15,691 total citations; 359 total publications; best world rank #22
Inserm
15,691Total citations
359Total publications
66H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Cells and Metastasis | Lifetime | 176 | FR 5 | 99.08 |
| Cancer Genomics and Diagnostics | Lifetime | 443 | FR 22 | 99.17 |
| Advanced Breast Cancer Therapies | Lifetime | 139 | FR 7 | 98.77 |
| Breast Cancer Treatment Studies | Lifetime | 475 | FR 23 | 98.57 |
| HER2/EGFR in Cancer Research | Lifetime | 388 | FR 15 | 98.33 |
| Metastasis and carcinoma case studies | Lifetime | 458 | FR 5 | 96.73 |
| Cancer Cells and Metastasis | 2021-2025 | 22 | FR 1 | 98.12 |
| Cancer Genomics and Diagnostics | 2021-2025 | 126 | FR 7 | 98.97 |
| Breast Cancer Treatment Studies | 2021-2025 | 61 | FR 3 | 99.13 |
| Advanced Breast Cancer Therapies | 2021-2025 | 39 | FR 4 | 99.25 |
| HER2/EGFR in Cancer Research | 2021-2025 | 81 | FR 5 | 98.68 |
| Estrogen and related hormone effects | 2021-2025 | 92 | FR 1 | 93.13 |
| Cancer-related Molecular Pathways | 2021-2025 | 147 | FR 3 | 91.75 |
| Cancer Treatment and Pharmacology | 2021-2025 | 470 | FR 34 | 91.07 |